secwatch.observer — SEC 8-K summary
======================================

Issuer:     Rein Therapeutics, Inc. (RNTX)
CIK:        0001420565
Form:       8-K
Filed at:   2026-09-04T20:31:51+00:00
Accession:  0001193125-26-383726
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Rein Therapeutics posts LTI-03 presentation; no specifics in filing
-------------------------------------------------------------------

- On September 4, 2026, Rein Therapeutics published a presentation on LTI-03 on its IR website.
- The presentation is attached as Exhibit 99.1; the provided text does not include its content.
- No financial, clinical, or regulatory updates are disclosed in the 8-K body.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1420565/000119312526383726/0001193125-26-383726-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1420565/000119312526383726/d111215d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-383726

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer